Phenotypic and genotypic monitoring of Schistosoma mansoni in Tanzanian schoolchildren five years into a preventative chemotherapy national control programme

[1]  J. Cotton,et al.  Reduced Efficacy of Praziquantel Against Schistosoma mansoni Is Associated With Multiple Rounds of Mass Drug Administration , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  M. Reis,et al.  Repeated praziquantel treatments remodel the genetic and spatial landscape of schistosomiasis risk and transmission. , 2016, International journal for parasitology.

[3]  Schistosomiasis: number of people treated worldwide in 2014. , 2016, Releve epidemiologique hebdomadaire.

[4]  R. Anderson,et al.  Studies of the Transmission Dynamics, Mathematical Model Development and the Control of Schistosome Parasites by Mass Drug Administration in Human Communities. , 2016, Advances in parasitology.

[5]  J. Boissier,et al.  Genetic diversity, multiplicity of infection and population structure of Schistosoma mansoni isolates from human hosts in Ethiopia , 2015, BMC Genetics.

[6]  J. Zwang,et al.  Clinical Efficacy and Tolerability of Praziquantel for Intestinal and Urinary Schistosomiasis—A Meta-analysis of Comparative and Non-comparative Clinical Trials , 2014, PLoS neglected tropical diseases.

[7]  E. Loker,et al.  No Apparent Reduction in Schistosome Burden or Genetic Diversity Following Four Years of School-Based Mass Drug Administration in Mwea, Central Kenya, a Heavy Transmission Area , 2014, PLoS neglected tropical diseases.

[8]  J. Webster,et al.  Sensitivity and Specificity of Multiple Kato-Katz Thick Smears and a Circulating Cathodic Antigen Test for Schistosoma mansoni Diagnosis Pre- and Post-repeated-Praziquantel Treatment , 2014, PLoS neglected tropical diseases.

[9]  P. Hotez,et al.  The contribution of mass drug administration to global health: past, present and future , 2014, Philosophical Transactions of the Royal Society B: Biological Sciences.

[10]  Zhian N. Kamvar,et al.  Poppr: an R package for genetic analysis of populations with clonal, partially clonal, and/or sexual reproduction , 2014, PeerJ.

[11]  F. Balloux,et al.  Regular treatments of praziquantel do not impact on the genetic make-up of Schistosoma mansoni in Northern Senegal. , 2013, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[12]  D. Rollinson,et al.  Population genetics of Schistosoma haematobium: development of novel microsatellite markers and their application to schistosomiasis control in Mali , 2011, Parasitology.

[13]  J. Webster,et al.  In Vitro Praziquantel Test Capable of Detecting Reduced In Vivo Efficacy in Schistosoma mansoni Human Infections , 2010, The American journal of tropical medicine and hygiene.

[14]  J. Webster,et al.  Genetic consequences of mass human chemotherapy for Schistosoma mansoni: population structure pre- and post-praziquantel treatment in Tanzania. , 2010, The American journal of tropical medicine and hygiene.

[15]  Jinlian Wang,et al.  COLONY: a program for parentage and sibship inference from multilocus genotype data , 2010, Molecular ecology resources.

[16]  M. Steinauer.  The sex lives of parasites: investigating the mating system and mechanisms of sexual selection of the human pathogen Schistosoma mansoni. , 2009, International journal for parasitology.

[17]  Y. Zhang,et al.  The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002–2008 , 2009, Parasitology.

[18]  Peter J Hotez,et al.  Rescuing the bottom billion through control of neglected tropical diseases , 2009, The Lancet.

[19]  H. Carabin,et al.  Population Genetics of Schistosoma japonicum within the Philippines Suggest High Levels of Transmission between Humans and Dogs , 2008, PLoS neglected tropical diseases.

[20]  J. Webster,et al.  Evolutionary concepts in predicting and evaluating the impact of mass chemotherapy schistosomiasis control programmes on parasites and their hosts , 2008, Evolutionary applications.

[21]  J. Goudet,et al.  A step-by-step tutorial to use HierFstat to analyse populations hierarchically structured at multiple levels. , 2007, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[22]  C. Donnelly,et al.  Schistosoma haematobium infection and morbidity before and after large-scale administration of praziquantel in Burkina Faso. , 2007, The Journal of infectious diseases.

[23]  D. Rollinson,et al.  Development and application of an ethically and epidemiologically advantageous assay for the multi-locus microsatellite analysis of Schistosoma mansoni , 2006, Parasitology.

[24]  Luc Kestens,et al.  Human schistosomiasis , 2006, The Lancet.

[25]  R. Poulin,et al.  Molecular ecology of parasites: elucidating ecological and microevolutionary processes , 2005, Molecular ecology.

[26]  Kejun Liu,et al.  PowerMarker: an integrated analysis environment for genetic marker analysis , 2005, Bioinform..

[27]  J. Goudet.  HIERFSTAT , a package for R to compute and test hierarchical F -statistics , 2005 .

[28]  M. Whitlock,et al.  Estimating effective population size and migration rates from genetic samples over space and time. , 2003, Genetics.

[29]  M. Doenhoff,et al.  In vitro responses of praziquantel-resistant and -susceptible Schistosoma mansoni to praziquantel. , 2001, International journal for parasitology.

[30]  T. Day,et al.  Stability and reproductive fitness of Schistosoma mansoni isolates with decreased sensitivity to praziquantel. , 2001, International journal for parasitology.

[31]  J. Goudet.  FSTAT (Version 1.2): A Computer Program to Calculate F-Statistics , 1995 .

[32]  A. Cheever.  A quantitative post-mortem study of Schistosomiasis mansoni in man. , 1968, The American journal of tropical medicine and hygiene.

[33]  L. Cavalli-Sforza,et al.  PHYLOGENETIC ANALYSIS: MODELS AND ESTIMATION PROCEDURES , 1967, Evolution; international journal of organic evolution.